Malignant childhood proptosis: study of 104 cases

Sameer Bakhshi1, Preetpaul Singh, Nikhil Chawla

  • 1Department of Medical Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India. sambakh@hotmail.com

Insights

Pediatric malignant proptosis is often caused by secondary tumors like retinoblastoma. Bilateral proptosis and specific blood count changes may indicate metastatic disease, suggesting hematologic work-up before invasive procedures.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Hematology

Background:

  • Malignant proptosis in children is a serious condition requiring prompt diagnosis.
  • Understanding the common causes and associated clinical features is crucial for effective management.

Purpose of the Study:

  • To analyze the incidence and causes of malignant proptosis in pediatric cancer patients.
  • To identify clinical and hematological factors associated with proptosis, particularly bilateral cases.

Main Methods:

  • Retrospective analysis of children (<=18 years) with malignant proptosis.
  • Data collected from July 2003 to December 2006 at a tertiary cancer center's ophthalmic tumor clinic.

Main Results:

  • Proptosis incidence was 4.9% among pediatric cancer patients.
  • Secondary tumors were the most common cause (59.6%), with retinoblastoma being the leading diagnosis (51%).
  • Bilateral proptosis (13.5%) was predominantly linked to metastatic tumors and associated with altered hemogram parameters (lower hemoglobin/platelets, higher WBC).

Conclusions:

  • Retinoblastoma and other secondary tumors are primary causes of malignant proptosis in children.
  • Bilateral proptosis and specific hemogram findings warrant a hematologic work-up to rule out metastatic disease prior to imaging or biopsy.